Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Molecular probe developed for optical imaging of Bcl-2 expression during chemotherapy

June 23, 2014

Novel candidate PET ligands for central histamine H3 receptors

June 23, 2014

Novel Ga-68 PET bone-targeting agent tested in vivo, ex vivo and in metastatic bone cancer patients

June 20, 2014

FDPA shows potential for imaging bacterial infections in the lung

June 18, 2014

Radiosynthesis and microPET evaluation of F-18 CRF1 receptor PET tracer presented

June 18, 2014

PSMA ligand evaluated in patients for the diagnosis of prostate cancer

June 17, 2014

[18F]-GP1: a potential a PET tracer for thrombi in humans

June 17, 2014

FDA approves Lymphoseek for use in head and neck cancer

June 16, 2014

Preclinical safety of [18F]FBYBF-2 validates dosimetric studies in humans

June 16, 2014

FDA approves Gadavist as a contrast agent for the evaluation of breast cancer

June 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...